Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phoenix Biomolecular Engineering Foundation (PBEF) is a non-profit biotechnology research organization based in the San Francisco Bay Area. The foundation is dedicated to the development of advanced molecular engineering technologies, specifically focusing on synthetic DNA analogs and artificial genetic systems. These technologies are designed to enhance the precision and sensitivity of molecular diagnostics and to create novel therapeutic modalities for complex diseases. PBEF's core mission is to bridge the gap between fundamental scientific discovery and clinical application, particularly in the fields of oncology and infectious diseases. Through its Phoenix DNA platform, the organization works to overcome the inherent limitations of natural nucleic acids in medical and diagnostic settings. The foundation collaborates with academic and industrial partners to translate its molecular innovations into practical healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Biomolecular Engineering Foundation.